Select any link to see items in a related category.
more general categories information about this item 03. Biological Effects of Specific Chemicals 03. Biological Effects of Specific Chemicals biochemical uses [CHEBI:52206] (3306) enzyme inhibitor [CHEBI:23924] (825) protein kinase inhibitor [CHEBI:37699] (69) tyrosine kinase inhibitor [CHEBI:38637] (38) regorafenib hydrate [CHEBI:68646] (1) aetiopathogenetic uses [CHEBI:52209] (178) hepatotoxic agent [CHEBI:50908] (8) regorafenib hydrate [CHEBI:68646] (1) 05. Industrial Uses 05. Industrial Uses pharmaceutical [CHEBI:52217] (1978) drug [CHEBI:23888] (1930) antineoplastic agent [CHEBI:35610] (760) regorafenib hydrate [CHEBI:68646] (1) 08. Chemical Category 08. Chemical Category polyatomic entity [CHEBI:36357] (18777) heteroatomic molecular entity [CHEBI:37577] (13672) addition compound [CHEBI:35504] (113) hydrate [CHEBI:35505] (111) regorafenib hydrate [CHEBI:68646] (1) ChEBI Compound Accession Identifier: [CHEBI:68646] ChEBI Compound Description: A hydrate that is the monohydrate form of anhydrous regorafenib. Used for for the treatment of metastatic colorectal cancer in patients who have previously received chemotherapy, anti-EGFR or anti-VEGF therapy. ChEBI Compound Identification Number: 68646 ChEBI InChI Value: "InChI=1S/C21H15ClF4N4O3.H2O/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26;/h2-10H,1H3,(H,27,31)(H2,29,30,32);1H2" ChEBI InChIKey Value: ZOPOQLDXFHBOIH-UHFFFAOYSA-N ChEBI Compound Name: regorafenib hydrate ChEBI SMILES Value: O.CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1 ChEBI Substance ID: 160645725 ChEBI URL: ChEBI:68646 ChemSpider ID: NS Ontomatica Chemical Accession Key (OnChAKey): ZOPOQLDXFHBOIH_UHFFFAOYSA_N_000_000000 PubChem Compound ID: 24768591